Trials / No Longer Available
No Longer AvailableNCT00583401
PFO ACCESS Registry
Patent Foramen Ovale Closure With the AMPLATZER PFO OCCLUDER in Patients With Recurrent Cryptogenic Stroke Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale Who Have Failed Conventional Drug Therapy
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Closure of Patent Foramen Ovale with the AMPLATZER® PFO OCCLUDER in patients with at least two cryptogenic strokes due to presumed paradoxical embolism through a patent foramen ovale and who have failed conventional therapy.
Detailed description
The primary objective of the PFO Access Registry is to allow access to the AMPLATZER PFO Occluder in subjects with a PFO who have already experienced at least two cryptogenic strokes due to presumed paradoxical embolism through a patent foramen ovale and who have failed conventional drug therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Device closure with the AMPLATZER PFO Occluder | Device closure with the AMPLATZER PFO Occluder |
Timeline
- First posted
- 2007-12-31
- Last updated
- 2019-02-04
Source: ClinicalTrials.gov record NCT00583401. Inclusion in this directory is not an endorsement.